Comparison of 11 respiratory pathogens among hospitalized children before and during the COVID-19 epidemic in Shenzhen, China.
Adenoviruses, Human
/ genetics
Adolescent
Antibiosis
COVID-19
/ epidemiology
Child
Child, Hospitalized
Child, Preschool
China
Enterovirus
/ genetics
Female
Humans
Infant
Influenza A virus
/ genetics
Male
Metapneumovirus
/ genetics
Mycoplasma pneumoniae
/ genetics
Nasopharynx
/ microbiology
Prevalence
Respiratory Syncytial Viruses
/ genetics
Respiratory Tract Diseases
/ epidemiology
Respirovirus
/ genetics
SARS-CoV-2
/ genetics
Children
Prevalence
Respiratory pathogens
SARS-CoV-2
Journal
Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645
Informations de publication
Date de publication:
09 10 2021
09 10 2021
Historique:
received:
20
07
2021
accepted:
20
09
2021
entrez:
10
10
2021
pubmed:
11
10
2021
medline:
25
2
2023
Statut:
epublish
Résumé
The effect of SARS-CoV-2 on existing respiratory pathogens in circulation remains uncertain. This study aimed to assess the impact of SARS-CoV-2 on the prevalence of respiratory pathogens among hospitalized children. This study enrolled hospitalized children with acute respiratory infections in Shenzhen Children's Hospital from September to December 2019 (before the COVID-19 epidemic) and those from September to December 2020 (during the COVID-19 epidemic). Nasopharyngeal swabs were collected, and respiratory pathogens were detected using multiplex PCR. The absolute case number and detection rates of 11 pathogens were collected and analyzed. A total of 5696 children with respiratory tract infection received multiplex PCR examination for respiratory pathogens: 2298 from September to December 2019 and 3398 from September to December 2020. At least one pathogen was detected in 1850 (80.5%) patients in 2019, and in 2380 (70.0%) patients in 2020; the detection rate in 2020 was significantly lower than that in 2019.The Influenza A (InfA) detection rate was 5.6% in 2019, but 0% in 2020. The detection rates of Mycoplasma pneumoniae, Human adenovirus, and Human rhinovirus also decreased from 20% (460), 8.9% (206), and 41.8% (961) in 2019 to 1.0% (37), 2.1% (77), and 25.6% (873) in 2020, respectively. In contrast, the detection rates of Human respiratory syncytial virus, Human parainfluenza virus, and Human metapneumovirus increased from 6.6% (153), 9.9% (229), and 0.5% (12) in 2019 to 25.6% (873), 15.5% (530), and 7.2% (247) in 2020, respectively (p < 0.0001). Successful containment of seasonal influenza as a result of COVID-19 control measures will ensure we are better equipped to deal with future outbreaks of both influenza and COVID-19.Caused by virus competition, the detection rates of Human respiratory syncytial virus, Human parainfluenza virus, and Human metapneumovirus increased in Shenzhen,that reminds us we need to take further monitoring and preventive measures in the next epidemic season.
Sections du résumé
BACKGROUND
The effect of SARS-CoV-2 on existing respiratory pathogens in circulation remains uncertain. This study aimed to assess the impact of SARS-CoV-2 on the prevalence of respiratory pathogens among hospitalized children.
METHODS
This study enrolled hospitalized children with acute respiratory infections in Shenzhen Children's Hospital from September to December 2019 (before the COVID-19 epidemic) and those from September to December 2020 (during the COVID-19 epidemic). Nasopharyngeal swabs were collected, and respiratory pathogens were detected using multiplex PCR. The absolute case number and detection rates of 11 pathogens were collected and analyzed.
RESULTS
A total of 5696 children with respiratory tract infection received multiplex PCR examination for respiratory pathogens: 2298 from September to December 2019 and 3398 from September to December 2020. At least one pathogen was detected in 1850 (80.5%) patients in 2019, and in 2380 (70.0%) patients in 2020; the detection rate in 2020 was significantly lower than that in 2019.The Influenza A (InfA) detection rate was 5.6% in 2019, but 0% in 2020. The detection rates of Mycoplasma pneumoniae, Human adenovirus, and Human rhinovirus also decreased from 20% (460), 8.9% (206), and 41.8% (961) in 2019 to 1.0% (37), 2.1% (77), and 25.6% (873) in 2020, respectively. In contrast, the detection rates of Human respiratory syncytial virus, Human parainfluenza virus, and Human metapneumovirus increased from 6.6% (153), 9.9% (229), and 0.5% (12) in 2019 to 25.6% (873), 15.5% (530), and 7.2% (247) in 2020, respectively (p < 0.0001).
CONCLUSIONS
Successful containment of seasonal influenza as a result of COVID-19 control measures will ensure we are better equipped to deal with future outbreaks of both influenza and COVID-19.Caused by virus competition, the detection rates of Human respiratory syncytial virus, Human parainfluenza virus, and Human metapneumovirus increased in Shenzhen,that reminds us we need to take further monitoring and preventive measures in the next epidemic season.
Identifiants
pubmed: 34627307
doi: 10.1186/s12985-021-01669-y
pii: 10.1186/s12985-021-01669-y
pmc: PMC8501916
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
202Subventions
Organisme : science and technology planning project of shenzhen municipality
ID : SZGSP012
Organisme : science and technology planning project of shenzhen municipality
ID : SZXK032
Informations de copyright
© 2021. The Author(s).
Références
Acta Paediatr Jpn. 1988 Jun;30(3):231-9
pubmed: 3150206
Public Health. 2020 Dec;189:123-125
pubmed: 33221646
J Clin Virol. 2014 Aug;60(4):402-7
pubmed: 24915939
Infect Dis (Lond). 2021 Jul;53(7):488-497
pubmed: 33612055
Turk Pediatri Ars. 2015 Dec 01;50(4):217-25
pubmed: 26884691
Lancet Public Health. 2020 May;5(5):e279-e288
pubmed: 32311320
Emerg Infect Dis. 2020 Aug;26(8):1933-1935
pubmed: 32339092
J Infect Dev Ctries. 2020 Sep 30;14(9):953-956
pubmed: 33031079
Pediatr Transplant. 2021 Aug;25(5):e14025
pubmed: 33904211
Vet Microbiol. 2014 Feb 21;169(1-2):18-32
pubmed: 24418046
J Med Virol. 2019 Sep;91(9):1625-1632
pubmed: 31066075
J Glob Health. 2021 Mar 01;11:05007
pubmed: 33791096
Clin Infect Dis. 2021 Jun 15;72(12):2196-2198
pubmed: 32888007
PLoS One. 2016 May 19;11(5):e0155589
pubmed: 27196110
PLoS Pathog. 2017 Jun 22;13(6):e1006419
pubmed: 28640898
JAMA. 2020 May 19;323(19):1969-1971
pubmed: 32275293
Pediatr Int. 2005 Aug;47(4):412-6
pubmed: 16091079
J Med Internet Res. 2020 Aug 20;22(8):e21257
pubmed: 32750008
Virol J. 2016 Mar 08;13:39
pubmed: 26952107
Nat Rev Microbiol. 2021 Aug;19(8):528-545
pubmed: 33753932
Influenza Other Respir Viruses. 2020 Nov;14(6):647-657
pubmed: 31670892
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290901
J Infect. 2021 Sep;83(3):281-293
pubmed: 34161818